Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de Endocrinologia e Metabolismo (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100105 |
Resumo: | ABSTRACT Objectives: To evaluate the performance of telemonitoring in detecting clinical and psychological needs and adherence to the protective measures imposed by the COVID-19 pandemic in addition to providing remote assistance for patients with type 1 diabetes (T1D) in a public university center in Brazil. Subjects and methods: Telemonitoring protocol included phone calls and e-mails. Patients were asked to rate COVID-19-like symptoms, psychological symptoms, epidemiological issues, and adherence to diabetes management (insulin, exercise, and diet) using a 0-to-10 scale. An e-mail address and phone number were offered for further contact if needed. Clinical, demographic, and laboratorial data from the consultations before the pandemic were collected from medical records. Results: Among 321 patients with a previously scheduled consultation over the first 15 weeks of social distancing, 237 (73.8%) could be successfully contacted. Of these, 207 (87.3%) were exclusively evaluated by telemonitoring (190 only by phone or text message and 17 who were also reached by email), and 30 (12.7%) patients attended the consultation for medical reasons detected during the telephone screening. Overall, 44 (18.5%) patients reported COVID-19-like symptoms. One (2.3%) patient was hospitalized and subsequently died. Psychological symptoms were reported by 137 (60.4%) patients and 30 (12.7%) required remote psychological assistance. Appropriate social distancing was performed by 203 (87.9%) patients, and 221 (97.8%) referred use of masks. Conclusions: Telemonitoring T1D patients during the pandemic helped reduce the need for in-person consultations, detect clinical and psychological needs, and offer support to patients in addition to monitoring suspected COVID-19 cases and the adherence to protective measures. |
id |
SBEM-1_e287de3111273239717502fab4ab4a89 |
---|---|
oai_identifier_str |
oai:scielo:S2359-39972021000100105 |
network_acronym_str |
SBEM-1 |
network_name_str |
Arquivos de Endocrinologia e Metabolismo (Online) |
repository_id_str |
|
spelling |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?Type 1 diabetesCOVID-19telemonitoringABSTRACT Objectives: To evaluate the performance of telemonitoring in detecting clinical and psychological needs and adherence to the protective measures imposed by the COVID-19 pandemic in addition to providing remote assistance for patients with type 1 diabetes (T1D) in a public university center in Brazil. Subjects and methods: Telemonitoring protocol included phone calls and e-mails. Patients were asked to rate COVID-19-like symptoms, psychological symptoms, epidemiological issues, and adherence to diabetes management (insulin, exercise, and diet) using a 0-to-10 scale. An e-mail address and phone number were offered for further contact if needed. Clinical, demographic, and laboratorial data from the consultations before the pandemic were collected from medical records. Results: Among 321 patients with a previously scheduled consultation over the first 15 weeks of social distancing, 237 (73.8%) could be successfully contacted. Of these, 207 (87.3%) were exclusively evaluated by telemonitoring (190 only by phone or text message and 17 who were also reached by email), and 30 (12.7%) patients attended the consultation for medical reasons detected during the telephone screening. Overall, 44 (18.5%) patients reported COVID-19-like symptoms. One (2.3%) patient was hospitalized and subsequently died. Psychological symptoms were reported by 137 (60.4%) patients and 30 (12.7%) required remote psychological assistance. Appropriate social distancing was performed by 203 (87.9%) patients, and 221 (97.8%) referred use of masks. Conclusions: Telemonitoring T1D patients during the pandemic helped reduce the need for in-person consultations, detect clinical and psychological needs, and offer support to patients in addition to monitoring suspected COVID-19 cases and the adherence to protective measures.Sociedade Brasileira de Endocrinologia e Metabologia2021-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100105Archives of Endocrinology and Metabolism v.65 n.1 2021reponame:Arquivos de Endocrinologia e Metabolismo (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.20945/2359-3997000000309info:eu-repo/semantics/openAccessMatheus,Alessandra Saldanha de MattosCabizuca,Carolina AlvesTannus,Lucianne Righetti MonteiroPassos,Aline CaminSchmidt,Amábile CristyneGouveia,Ana Tarasiuk dePessoa,Bruno Moraes de AlbuquerqueMatheus,Felipe CerqueiraYang,Gabriela Yea-HueyDivino,Josimara Araujo da SilvaMathiles,Juliana AffonsoTeixeira,Juliana LeiteBarroso,Luiza de SouzaBrito,Max Benicio da Fonseca deSuassuna,Paula MelicharCobas,Roberta Arnoldieng2021-02-25T00:00:00Zoai:scielo:S2359-39972021000100105Revistahttps://www.aem-sbem.com/https://old.scielo.br/oai/scielo-oai.php||aem.editorial.office@endocrino.org.br2359-42922359-3997opendoar:2021-02-25T00:00Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false |
dc.title.none.fl_str_mv |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
title |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
spellingShingle |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? Matheus,Alessandra Saldanha de Mattos Type 1 diabetes COVID-19 telemonitoring |
title_short |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
title_full |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
title_fullStr |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
title_full_unstemmed |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
title_sort |
Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful? |
author |
Matheus,Alessandra Saldanha de Mattos |
author_facet |
Matheus,Alessandra Saldanha de Mattos Cabizuca,Carolina Alves Tannus,Lucianne Righetti Monteiro Passos,Aline Camin Schmidt,Amábile Cristyne Gouveia,Ana Tarasiuk de Pessoa,Bruno Moraes de Albuquerque Matheus,Felipe Cerqueira Yang,Gabriela Yea-Huey Divino,Josimara Araujo da Silva Mathiles,Juliana Affonso Teixeira,Juliana Leite Barroso,Luiza de Souza Brito,Max Benicio da Fonseca de Suassuna,Paula Melichar Cobas,Roberta Arnoldi |
author_role |
author |
author2 |
Cabizuca,Carolina Alves Tannus,Lucianne Righetti Monteiro Passos,Aline Camin Schmidt,Amábile Cristyne Gouveia,Ana Tarasiuk de Pessoa,Bruno Moraes de Albuquerque Matheus,Felipe Cerqueira Yang,Gabriela Yea-Huey Divino,Josimara Araujo da Silva Mathiles,Juliana Affonso Teixeira,Juliana Leite Barroso,Luiza de Souza Brito,Max Benicio da Fonseca de Suassuna,Paula Melichar Cobas,Roberta Arnoldi |
author2_role |
author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Matheus,Alessandra Saldanha de Mattos Cabizuca,Carolina Alves Tannus,Lucianne Righetti Monteiro Passos,Aline Camin Schmidt,Amábile Cristyne Gouveia,Ana Tarasiuk de Pessoa,Bruno Moraes de Albuquerque Matheus,Felipe Cerqueira Yang,Gabriela Yea-Huey Divino,Josimara Araujo da Silva Mathiles,Juliana Affonso Teixeira,Juliana Leite Barroso,Luiza de Souza Brito,Max Benicio da Fonseca de Suassuna,Paula Melichar Cobas,Roberta Arnoldi |
dc.subject.por.fl_str_mv |
Type 1 diabetes COVID-19 telemonitoring |
topic |
Type 1 diabetes COVID-19 telemonitoring |
description |
ABSTRACT Objectives: To evaluate the performance of telemonitoring in detecting clinical and psychological needs and adherence to the protective measures imposed by the COVID-19 pandemic in addition to providing remote assistance for patients with type 1 diabetes (T1D) in a public university center in Brazil. Subjects and methods: Telemonitoring protocol included phone calls and e-mails. Patients were asked to rate COVID-19-like symptoms, psychological symptoms, epidemiological issues, and adherence to diabetes management (insulin, exercise, and diet) using a 0-to-10 scale. An e-mail address and phone number were offered for further contact if needed. Clinical, demographic, and laboratorial data from the consultations before the pandemic were collected from medical records. Results: Among 321 patients with a previously scheduled consultation over the first 15 weeks of social distancing, 237 (73.8%) could be successfully contacted. Of these, 207 (87.3%) were exclusively evaluated by telemonitoring (190 only by phone or text message and 17 who were also reached by email), and 30 (12.7%) patients attended the consultation for medical reasons detected during the telephone screening. Overall, 44 (18.5%) patients reported COVID-19-like symptoms. One (2.3%) patient was hospitalized and subsequently died. Psychological symptoms were reported by 137 (60.4%) patients and 30 (12.7%) required remote psychological assistance. Appropriate social distancing was performed by 203 (87.9%) patients, and 221 (97.8%) referred use of masks. Conclusions: Telemonitoring T1D patients during the pandemic helped reduce the need for in-person consultations, detect clinical and psychological needs, and offer support to patients in addition to monitoring suspected COVID-19 cases and the adherence to protective measures. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100105 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100105 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.20945/2359-3997000000309 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
dc.source.none.fl_str_mv |
Archives of Endocrinology and Metabolism v.65 n.1 2021 reponame:Arquivos de Endocrinologia e Metabolismo (Online) instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) instacron:SBEM |
instname_str |
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
instacron_str |
SBEM |
institution |
SBEM |
reponame_str |
Arquivos de Endocrinologia e Metabolismo (Online) |
collection |
Arquivos de Endocrinologia e Metabolismo (Online) |
repository.name.fl_str_mv |
Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
repository.mail.fl_str_mv |
||aem.editorial.office@endocrino.org.br |
_version_ |
1752122517490761728 |